| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 74,439 | 60,475 | 55,923 | 74,497 | | Cost of Revenue | 38,628 | 29,029 | 24,937 | 36,228 | | | Gross Profit | 35,811 | 31,446 | 30,986 | 38,269 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,866 | 33,622 | 37,212 | 85,446 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 945 | (2,176) | (6,226) | (47,177) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 86 | 61 | 74 | 1,653 | | Earnings Before Interest And Taxes | 1,031 | (2,115) | (6,152) | (45,524) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,031 | (2,115) | (6,152) | (45,524) | | Income Tax Expense | 388 | (838) | (2,249) | (3,511) | | Minority Interest | 803 |
-
|
-
| 11,711 | | | | Net Income From Continuing Ops | 1,446 | (1,277) | (3,903) | (30,302) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,446 | (1,277) | (3,903) | (30,302) | | Preferred Stock And Other Adjustments | (1,081) | 268 | 813 |
-
| | | Net Income Applicable To Common Shares | $365 | ($1,009) | ($3,090) | ($30,302) |
|
0.51% Nasdaq 0.00%
Income Statement
